SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-043470
Filing Date
2013-02-07
Accepted
2013-02-07 16:13:36
Documents
11
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d453889d10q.htm 10-Q 354790
2 EX-31.1 d453889dex311.htm EX-31.1 9280
3 EX-31.2 d453889dex312.htm EX-31.2 9257
4 EX-32.1 d453889dex321.htm EX-32.1 3977
5 EX-32.2 d453889dex322.htm EX-32.2 3856
  Complete submission text file 0001193125-13-043470.txt   2743719

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lfvn-20121231.xml EX-101.INS 315474
7 XBRL TAXONOMY EXTENSION SCHEMA lfvn-20121231.xsd EX-101.SCH 26382
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lfvn-20121231_cal.xml EX-101.CAL 44994
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lfvn-20121231_def.xml EX-101.DEF 150966
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lfvn-20121231_lab.xml EX-101.LAB 235137
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lfvn-20121231_pre.xml EX-101.PRE 176525
Mailing Address 9815 S. MONROE STREET SUITE 100 SANDY UT 84070
Business Address 9815 S. MONROE STREET SUITE 100 SANDY UT 84070 858-312-8000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 13582599
SIC: 2834 Pharmaceutical Preparations